| 1 | valpharma pharmaceutical company pharmaceutical | | | | | | | 8 | 2.19% |
| 2 | industryvalpharma pharmaceutical company pharmaceutical | | | | | | | 7 | 1.92% |
| 3 | in the pharmaceutical and | | | | | | | 2 | 0.55% |
| 4 | toggle navigation valpharma pharmaceutical | | | | | | | 1 | 0.27% |
| 5 | their life both in | | | | | | | 1 | 0.27% |
| 6 | i authorize the processing | | | | | | | 1 | 0.27% |
| 7 | authorize the processing of | | | | | | | 1 | 0.27% |
| 8 | both in the pharmaceutical | | | | | | | 1 | 0.27% |
| 9 | life both in the | | | | | | | 1 | 0.27% |
| 10 | every stage of their | | | | | | | 1 | 0.27% |
| 11 | of their life both | | | | | | | 1 | 0.27% |
| 12 | stage of their life | | | | | | | 1 | 0.27% |
| 13 | food supplement sectors pharmaceuticals | | | | | | | 1 | 0.27% |
| 14 | at every stage of | | | | | | | 1 | 0.27% |
| 15 | people at every stage | | | | | | | 1 | 0.27% |
| 16 | the processing of the | | | | | | | 1 | 0.27% |
| 17 | navigation valpharma pharmaceutical company | | | | | | | 1 | 0.27% |
| 18 | pharmaceuticals solid oral dosage | | | | | | | 1 | 0.27% |
| 19 | supplement sectors pharmaceuticals solid | | | | | | | 1 | 0.27% |
| 20 | sectors pharmaceuticals solid oral | | | | | | | 1 | 0.27% |
| 21 | designed for the needs | | | | | | | 1 | 0.27% |
| 22 | solid oral dosage products | | | | | | | 1 | 0.27% |
| 23 | oral dosage products imp | | | | | | | 1 | 0.27% |
| 24 | us i authorize the | | | | | | | 1 | 0.27% |
| 25 | with us i authorize | | | | | | | 1 | 0.27% |
| 26 | touch with us i | | | | | | | 1 | 0.27% |
| 27 | batches psychotropic substances tech | | | | | | | 1 | 0.27% |
| 28 | psychotropic substances tech transfer | | | | | | | 1 | 0.27% |
| 29 | substances tech transfer nutraceuticals | | | | | | | 1 | 0.27% |
| 30 | tech transfer nutraceuticals and | | | | | | | 1 | 0.27% |
| 31 | in touch with us | | | | | | | 1 | 0.27% |
| 32 | keep in touch with | | | | | | | 1 | 0.27% |
| 33 | for the needs of | | | | | | | 1 | 0.27% |
| 34 | develop product lines designed | | | | | | | 1 | 0.27% |
| 35 | lines designed for the | | | | | | | 1 | 0.27% |
| 36 | food supplements and cosmetics | | | | | | | 1 | 0.27% |
| 37 | imghomepagevalpharmaimghomepagevalpharma expertise and excellence | | | | | | | 1 | 0.27% |
| 38 | certification regulators and the | | | | | | | 1 | 0.27% |
| 39 | the processing reported in | | | | | | | 1 | 0.27% |
| 40 | of the processing reported | | | | | | | 1 | 0.27% |